Frequency and management of germ-cell tumors in a third-world country

Oncology Reports

Volumn 5, Issue 5, 1998, Pages 1241-1244

  Denic, Srdjan ^a  

^a University Hospital   (United States)

Author keywords

Case management; Developing countries; Germ cell tumor; Incidence; Mortality; Testicular cancer

Indexed keywords

ADULT; ARTICLE; CANCER CLASSIFICATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FOLLOW UP; HUMAN; IRAQ; MALE; PRIORITY JOURNAL; PROGNOSIS; TESTIS BIOPSY; TESTIS CANCER; TREATMENT OUTCOME;

EID: 0031829368     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.5.5.1241     Document Type: Article

References (9)

1. Einhorn LH and Donohue J: Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer. Ann Intern Med 87: 293-298, 1977.
2. Feuer EJ, Kessler LG, Baker SG, et al: The impact of break-through clinical trials on survival in population-based tumor registries. J Clin Epidemiol 44: 141-143, 1991.
3. Boyle P and Maisonneuve P: Therapy for testicular cancer in Central and Eastern Europe (letter). Lancet 335: 1033, 1990.
4. Adami HO, Bergstrom R, Mohner M, et al: Testicular cancer in nine Northern European countries. Int J Cancer 59: 33-38, 1994.
5. Miller BA, Ries LAG, Hankey BF, et al (eds): SEER Cancer Statistics Review: 1973-1990. NIH Pub. No. 93-2789. Bethesda, MD, 1993.
6. Madej G: Treatment of testicular cancer in Poland (letter). Lancet 336: 440, 1990.
7. Zatonski W, Jeziorski K and Tyczynski J: Testicular cancer in Poland (letter). Lancet 336: 183, 1990.
8. El-Hassani M: Results of Iraqi cancer registry: 1986-1988. Iraqi Cancer Board, Iraqi Cancer Registry Center. Baghdad, Institute of Radiology and Nuclear Medicine, 1990.
9. Capelouto CC, Clark PE, Ransil BJ and Loughlin KR: A review of scrotal violation in testicular cancer: is adjuvant local therapy necessary? J Urol 73: 981-985, 995.